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Background
Skin barrier dysfunction contributes to development of
atopic dermatitis (AD). We performed a prospective,
randomized controlled trial to investigate whether pro-
tecting the skin barrier with a moisturizer prevents
development of AD and allergic sensitization.
Methods
We enrolled 118 neonates at high risk for AD (based on
family history of AD in parents or siblings) and rando-
mized to intervention group or control group (59 infants
for each group). In intervention group, we applied emul-
sion-type moisturizer daily on a whole body during the
first 32 weeks of life. All infants were scheduled to visit
at weeks 4, 12, 24 and 32 of life and were examined the
skin condition. The onset of AD (eczematous skin last-
ing more than 4 weeks) and eczema (lasting more than
2 weeks) were assessed by a blinded dermatologist,
based on the modified Hanifin and Rajka criteria. The
primary outcome was the cumulative incidence of AD
plus eczema (AD/eczema) at 32 weeks. The secondary
outcome, allergic sensitization, was evaluated based on
serum levels of allergen-specific IgE, measured by high-
sensitivity allergen microarray of diamond-like carbon-
coated chip (UMIN Clinical Trials Registry Identifier:
UMIN000004544).
Results
Among 118 infants, 47 developed AD/eczema (19 in the
intervention and 28 in the control group). The cumula-
tive incidence of AD/eczema was approximately 32%
fewer in infants randomized to intervention group than
that in controls by week 32 (P=0.012 in log-rank test).
We failed to reveal a statistically significant effect of
emollient-use on allergic sensitization based on the level
of IgE antibody against egg white at 0.34 kUA/L CAP-
FEIA equivalents. However, the sensitization was signifi-
cantly higher in infants who developed AD/eczema than
in those who did not (odds ratio, 2.86; 95% confidence
interval, 1.22-6.73).
Conclusions
Daily application of moisturizer during the first 32 weeks
of life reduces the risk of AD/eczema in high-risk infants.
Allergic sensitization during this time period is associated
with the presence of eczematous skin, but not with moist-
urizer use (J Allergy Clin Immunol. 2014; in press).
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